Atossa Therapeutics Inc.
(ATOS)
undefined
undefined%
At close: undefined
1.00
3.76%
After-hours Jan 06, 2025, 07:36 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| Net Income | -30.09M | -26.96M | -20.61M | -17.83M | -17.24M | -11.40M | -8.12M | -6.37M | -12.76M | -14.66M | -10.78M | -5.08M | -3.44M | -1.09M |
| Depreciation & Amortization | 23.00K | 8.00K | 23.00K | 46.52K | 52.79K | 44.20K | 128.99K | 303.48K | 272.63K | 564.46K | 472.93K | 130.55K | 15.62K | n/a |
| Stock-Based Compensation | 4.62M | 6.79K | 5.27K | 3.02M | 8.84M | 2.46M | 786.55K | 876.19K | 840.10K | 698.66K | 1.44M | 121.81K | 140.06K | 30.40K |
| Other Working Capital | 391.00K | -1.85M | -1.28M | -1.41M | -731.14K | -82.83K | -420.47K | -507.55K | -305.63K | 339.20K | -454.11K | 1.06M | -269.31K | 625.42K |
| Other Non-Cash Items | 2.99M | 3.00K | 5.62M | 938.79K | 5.81K | 2.69M | 192.82K | 1.60M | 840.10K | 3.05M | 389.77K | 121.81K | -3.44M | 73.00K |
| Deferred Income Tax | n/a | n/a | -5.62M | 2.36M | n/a | n/a | 760.16K | -712.86K | -3.47M | -489.37K | 663.10K | -91.93K | 3.53M | n/a |
| Change in Working Capital | 1.52M | -599.00K | -1.16M | -111.35K | -791.30K | -64.41K | -339.89K | -1.07M | 326.10K | 277.45K | -1.01M | 897.64K | -297.80K | 625.42K |
| Operating Cash Flow | -20.94M | -20.76M | -16.47M | -11.57M | -9.13M | -8.96M | -6.59M | -5.37M | -13.95M | -10.56M | -8.83M | -3.90M | -3.49M | -358.11K |
| Capital Expenditures | -14 | -27.00K | -9.00K | -9.37K | -7.63K | -110.91K | n/a | -9.21K | -130.74K | -343.26K | -489.81K | -134.58K | -136.93K | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | -4.70M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -4.70K | -9.00K | -9.37K | -7.63K | -110.91K | n/a | -9.21K | -157.68K | -343.26 | -245.37 | -30.00K | n/a | n/a |
| Investing Cash Flow | -14 | -4.73M | -9.00K | -9.37K | -7.63K | -110.91K | n/a | -9.21K | -288.42K | -343.26K | -489.81K | -134.58K | -136.93K | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -98.48K | n/a | -5.08K | -183.92K | 182.00K |
| Common Stock Repurchased | -1.48K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | 43.64M | 4.93M | 11.34M | 12.29M | 749.23K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Financial Cash Flow | -1.48K | n/a | 113.30M | 38.55M | 11.34M | 12.29M | 10.78M | 4.70M | 9.46M | 13.06M | 13.94M | 3.85M | 5.53M | 284.00K |
| Net Cash Flow | -22.43K | -25.49M | 96.82M | 26.97M | 2.20M | 3.22M | 4.19M | -687.93K | -4.78M | 2.16M | 4.62M | -185.62K | 1.90M | -74.11K |
| Free Cash Flow | -20.95K | -20.79M | -16.48M | -11.58M | -9.14M | -9.07M | -6.59M | -5.38M | -14.08M | -10.90M | -9.32M | -4.03M | -3.63M | -358.11K |